VALIANT CAPTIVIA Post-market Registry (VCOUS)
VALIANT CAPTIVIA Post-market Registry A Multi-center, Post-market, Non Interventional, Prospective Study
Sponsor: Medtronic Cardiovascular
Terminated
CIP was amended to include long-term FU but, not all sites accepted it so the nr. of pts participating in the extended FU will be small.
Other terminated trials from Medtronic Cardiovascular
Other Aortic Aneurysm, Thoracic trials with similar outcome
A observational or N/A phase clinical study on Aortic Aneurysm, Thoracic, this trial is terminated or withdrawn. The trial is conducted by Medtronic Cardiovascular and has accumulated 14 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2023 — Jul 2024 [monthly]
Terminated
-
Jan 2023 — Dec 2023 [monthly]
Terminated
▶ Show 9 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Terminated
-
Dec 2021 — Dec 2022 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
Feb 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiovascular
For direct contact, visit the study record on ClinicalTrials.gov .